Title :

Hiv and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy

Author(s) :

Lachatre, Marie [Auteur]
Pasquet, Armelle [Auteur]
Ajana, Faiza [Auteur]
Soudan, Benoit [Auteur]
Lion, Georges [Auteur]
Bocket, Laurence [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Cornavin, Pauline [Auteur]
Senneville, Eric [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Boufassa, Faroudy [Auteur]
Cheret, Antoine [Auteur]

Journal title :

AIDS (London, England)

Abbreviated title :

Aids

Volume number :

31

Pages :

451-453

Publication date :

2017-01-28

ISSN :

0269-9370

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Male hypogonadism is poorly defined in people living with HIV. Using a reliable free-testosterone assay, we examined the prevalence and risk factors of male hypogonadism among people living with HIV on effective antiretroviral ...
Show more >Male hypogonadism is poorly defined in people living with HIV. Using a reliable free-testosterone assay, we examined the prevalence and risk factors of male hypogonadism among people living with HIV on effective antiretroviral therapy. Male hypogonadism was found in 12.4% of patients, twice the rate reported in the general population of the same age. Two risk thresholds, namely 5 years of antiretroviral therapy and 19% total body fat, may help to identify patients at risk.Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

CHU Lille
Université de Lille

Collections :

• Laboratoire de virologie - ULR 3610
• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Submission date :

2019-12-09T16:54:29Z